Insulet (PODD) Misses Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts PODD Hot Sheet
Price: $134.68 -2.35%
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +18.1%
Financial Fact:
Other expense, net: -5.37M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Insulet (NASDAQ: PODD) reported Q4 EPS of $1.44, $0.02 worse than the analyst estimate of $1.46. Revenue for the quarter came in at $783.8 million versus the consensus estimate of $768.59 million.
For earnings history and earnings-related data on Insulet (PODD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Iran Has Resumed Producing Ballistic Missiles, U.S. and Middle East Officials Say - WSJ
- First Internet Bank promotes Nick Campbell to chief lending officer
- Goldman Sachs Reiterates Buy Rating on NVIDIA (NVDA)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
